HI HB767

Authorizes qualified clinical psychologists to prescribe psychotropic medications for mental health disorders, effective July 1, 2018, subject to specific education and training requirements.

Requires applicants to hold a post-doctoral master's degree in clinical psychopharmacology from an accredited institution, complete at least 800 hours of supervised clinical experience with minimum 100 patients, and pass the Psychopharmacology Examination for Psychologists.

Mandates prescribing psychologists work under collaborative agreements with primary care providers (physicians, osteopathic physicians, or advanced practice registered nurses), with monthly medication reviews required by the collaborating provider.

Establishes an exclusionary formulary prohibiting prescribing psychologists from prescribing Schedule I, II, or III controlled substances and narcotic drugs, with exception for ADHD stimulants regardless of schedule classification.

Requires prescribing psychologists to complete 18 hours of biennial continuing education in psychopharmacology and comply with Drug Enforcement Administration registration requirements; Board of Psychology to report to legislature by 2021 on implementation outcomes.